Novel Treatments for Neuromuscular Disorders

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 

Spotlight

August 2, 2017 Flex Pharma Reports Second Quarter 2017 Financial Results
Read More

August 1, 2017 Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US
Read More